INmune Bio fails to meet main goal in Alzheimer's treatment study
https://seekingalpha.com/news/4463660-inmune-bio-fails-to-meet-main-goal-in-alzheimers-treatment-study?source=feed_sector_healthcare
Jun 30, 2025 -
0
INmune Bio Phase 2 MINDFuL Study Of XPro In Alzheimers Disease Fails; Stock Down In Pre-market
https://www.rttnews.com/story.aspx?Id=3549728
Jun 30, 2025 - INmune Bio Inc. (INMB) Monday said that its Phase 2 MINDFuL study of XPro in patients with early Alzheimers Disease (AD) with biomarkers of inflammation did not meet its primary goal. The company's shares were more than 50% down in pre-market.
0
INmune Bio reverses early gains after stock offering
https://seekingalpha.com/news/4463366-inmune-bio-stock-falls-stock-offering?source=feed_sector_healthcare
Jun 27, 2025 -
0